Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at GVA's multiple
$1.1172.2% below market
0.94 ZNTL revenue / share×1.18x GVA P/S=$1.11
Market $3.99Implied $1.11
GVA · current priceP/S 1.18x
$119.30Latest market snapshot
Implied fair value · at ZNTL's multiple
$428.78259.4% above market
101.10 GVA revenue / share×4.24x ZNTL P/S=$428.78
Market $119.30Implied $428.78